MC-Val-Cit-PAB-DX8951 (Synonyms: MC-Val-Cit-PAB-DX8951) |
| Catalog No.GC64817 |
MC-Val-Cit-PAB-DX8951(MC-Val-Cit-PAB-DX8951)은 ADC용 약물-링커 접합체입니다. MC-Val-Cit-PAB-DX8951은 DNA 토포이소머라제 I DX-8951과 카텝신 절단 가능한 ADC 링커로 구성됩니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2504068-28-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MC-Val-Cit-PAB-DX8951 is a drug-linker conjugate for ADC. MC-Val-Cit-PAB-DX8951 is composed of a DNA topoisomerase I DX-8951 and a cathepsin cleavable ADC linker.
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1].
[1]. Anish Thomas, et al. Antibody-drug conjugates for cancer therapy. Lancet Oncol. 2016 Jun;17(6):e254-e262.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *